UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation

Seto-Salvia, N; Esteras, N; de Silva, R; de Pablo-Fernandez, E; Arber, C; Toomey, CE; Polke, JM; ... Warner, TT; + view all (2021) Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation. Journal of Cellular and Molecular Medicine 10.1111/jcmm.17136. (In press). Green open access

[thumbnail of J Cellular Molecular Medi - 2021 - Set ‐Salvia - Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10 16.pdf]
Preview
Text
J Cellular Molecular Medi - 2021 - Set ‐Salvia - Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10 16.pdf - Published Version

Download (560kB) | Preview

Abstract

The microtubule-associated protein tau gene (MAPT) 10+16 intronic mutation causes frontotemporal lobar degeneration (FTLD) by increasing expression of four-repeat (4R)-tau isoforms. We investigated the potential role for astrocytes in the pathogenesis of FTLD by studying the expression of 4R-tau. We derived astrocytes and neurons from induced pluripotent stem cells from two asymptomatic 10+16 carriers which, compared to controls, showed persistently increased 4R:3R-tau transcript and protein ratios in both cell types. However, beyond 300 days culture, 10+16 neurons showed less marked increase of this 4R:3R-tau transcript ratio compared to astrocytes. Interestingly, throughout maturation, both 10+16 carriers consistently displayed different 4R:3R-tau transcript and protein ratios. These elevated levels of 4R-tau in astrocytes implicate glial cells in the pathogenic process and also suggests a cell-type-specific regulation and may inform and help on treatment of pre-clinical tauopathies.

Type: Article
Title: Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/jcmm.17136
Publisher version: https://doi.org/10.1111/jcmm.17136
Language: English
Additional information: © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10140975
Downloads since deposit
11,856Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item